Our xenograft data suggested that suppression of tumor growth and metastasis occurs through the inhibition of the proliferation and the induction of apoptosis of the tumor cells, indicating the potential for miR-34a as a strategy for EGFR-targeted therapy. Here, EGFR is linked to neoplasm.